Biovista Featured in CHI’s InsightPharma Report on Drug Repositioning

July 7, 2010Announcements

Biovista Inc., Charlottesville, July 7, 2010:  Biovista today announced that it is a featured company in InsightPharma’s report on Drug Repositioning. The report “Drug Repositioning: Extracting Added Value from Prior R&D Investments” by Dr. Hermann A.M. Mucke explains the basic issues surrounding drug repositioning as a pipeline development and/or lice cycle management strategy, covers the … Read More

Biovista Nutrition application released for the Apple iPhone

January 28, 2009Announcements

Charlottesville, January 28, 2009 Biovista announced today the availability of its Biovista Nutrition application for the Apple iPhone. Biovista Nutrition for the iPhone (BNi) provides information on the interaction of nutritional supplements with drugs and diseases. “We are pleased to have launched this mobile application that can provide useful first level information to consumers at … Read More

Biovista contributes to clinical trials research on Wilms tumor and breast cancer.

October 1, 2007Announcements

Athens, Greece and Charlottesville, VA. Biovista has joined the European ACGT consortium developing advanced semantic technologies in support of post genomic clinical trials in cancer. The aim of this work is to create an IT grid-based infrastructure that will support clinicians and bio-researchers in clinical trial design and research in two cancer modalities: Wilms tumor … Read More